You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOUTHERN CALIFORNIA CHAPTER OF THE AMERICAN COLLEGE OF SURGEONS, CORONADO, CALIF, JAN 18, 1985
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (66)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Complications of Pelvic Exenteration

James G. Jakowatz, MD; David Porudominsky, MD; Daniel U. Riihimaki, MD; Margaret Kemeny, MD; William A. Kokal, MD; Patricia S. Braly, MD; José J. Terz, MD; J. David Beatty, MD

Arch Surg. 1985;120(11):1261-1265.


Abstract

• This report is based on a retrospective review of 104 patients who had undergone pelvic exenteration for advanced malignancy over a 29-year period (1956 to 1984, inclusive). Fifty-one patients (49%) developed major complications of the operative field involving the gastrointestinal tract (fistula or obstruction), the urinary tract (fistula, infection, or obstruction), or the wound (abscess, dehiscence/necrosis, or hemorrhage). No association was identified between the complication rate and organ of primary disease, extent of disease, tumor histology, or extent of resection. Patients receiving pelvic radiotherapy prior to exenteration had a much higher complication rate (39/58, 67%) than patients having had no radiotherapy (12/46, 26%). Reconstruction of the irradiated pelvis after exenteration by omental flap, colonic advancement, and/or myocutaneous flaps decreased the complication rate from 82% (27/33) to 48% (12/25). The operative mortality of pelvic exenteration was 2.9% and the actuarial five-year survival rate was 27%.

(Arch Surg 1985;120:1261-1265)



Author Affiliations

From the Departments of General Oncologic Surgery (Drs Jakowatz, Porudominsky, Riihimaki, Kemeny, Kokal, Terz, and Beatty) and Gynecologic Oncology (Dr Braly), City of Hope National Medical Center, Duarte, Calif.


Footnotes

Accepted for publication July 25, 1985.

Read before the Annual Meeting of the Southern California Chapter of the American College of Surgeons, Coronado, Calif, Jan 19, 1985.

Reprint requests to Department of General Oncologic Surgery, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010 (Dr Beatty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Total Pelvic Exenteration: A 50-Year Experience at the Ellis Fischel Cancer Center
Lopez et al.
Arch Surg 1994;129:390-396.
ABSTRACT  

Patterns of Recurrence After Pelvic Exenteration for Colorectal Adenocarcinoma
Hafner et al.
Arch Surg 1991;126:1510-1513.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.